Filing Details

Accession Number:
0000950170-25-011781
Form Type:
13G Filing
Publication Date:
2025-01-30 19:00:00
Filed By:
Malherbe Investments LLC
Company:
Enfusion Inc.
Filing Date:
2025-01-31
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Malherbe Investments LLC 0 6,870,386 6.79%
Stephen Malherbe 0 6,870,386 6.79%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC. Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.


SCHEDULE 13G



Comment for Type of Reporting Person:  Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC. Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.


SCHEDULE 13G


 
Malherbe Investments LLC
 
Signature:/s/ Stephen Malherbe
Name/Title:Sole Manager
Date:01/31/2025
 
Stephen Malherbe
 
Signature:/s/ Stephen Malherbe
Name/Title:Stephen Malherbe
Date:01/31/2025